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ABSTRACT  
 
Objective:  The objective of this evidence based medicine review is to determine if laser phototherapy 
is an effective treatment for herpes simplex labialis. 
 
Study Design: Review of one case study published in 2009, and two randomized controlled trials 
published in 2010 and 2013.  All studies were published in English. 
 
Data Source: One case study and two randomized controlled trials were retrieved from PubMed 
database to write this EBM review 
 
Outcomes measured: Decreases in healing time or size based on patient reporting, scoring systems, or 
photo documentation. 
 
Results: The study conducted by Marotti et al determined that the use of laser phototherapy decreases 
healing time and size of the herpes simplex labialis lesions.  In the study by De Carvalho et al, there was 
a significant difference in monthly average size of the lesions between the groups (p=0.013).  The study 
performed by Dougal et al showed a significant difference in healing time between the groups (p=0.01). 
 
Conclusions: Laser phototherapy is an effective and well tolerated treatment for herpes simplex labialis 
outbreaks. 
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Introduction 
Herpes simplex labialis, colloquially referred to as the “cold sore” is a viral infection most 
commonly of the trigeminal nerve ganglion.  The virus produces uncomfortable, embarrassing, and 
unsightly vesicular lesions that can recur throughout the lifetime of the patient, particularly during times 
of stress or immune system compromise.  It affects an estimated 20-40% of the U.S. population.1   
Herpes simplex labialis (most commonly HSV-1) is acquired most commonly through oral 
contact, often during childhood.2  It can also be passed to the genitals during oral sexual contact.2  
During the primary infection, replication occurs in the epithelium of the lips, face, and oral mucosa.3  
From this replication, viral progeny invade the basal epithelium and peripheral nerves.2  Virions 
additionally migrate to the trigeminal nerve ganglion, where they integrate into the host and enter into a 
latent phase.3  The virus can then become reactivated throughout the host’s life, especially in times of 
stress or immune system compromise.  During reactivation, the virus migrates peripherally down axons 
where it forms vesicular lesions on the lips or oral mucosa.3   
It is difficult to quantify the healthcare associated costs and office visits of herpes simplex 
labialis, as lesion etiology can be either HSV-1 or HSV-2, although most commonly HSV-1.  Either 
etiology is potentially possible, since cold sores could be HSV-2 contracted from oral sexual contact.  
Therefore, the classification of viral etiology by location and therefore associated costs and office visits 
can be challenging to distinguish. Additionally, the reported estimated costs for HSV are typically 
combined for cold sore and genital herpes.   
Signs of herpes simplex labialis outbreaks include a burning, tingling, or itching on the lip or oral 
mucosa just prior to eruption.  Painful vesicles then form on an erythematous and indurated base.  The 
vesicles rupture, leaving an open ulceration on the lip.  These outbreaks cause patients to seek medical  
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care for treatment of vesicular lesions, pain, and to hasten healing time. Treatment of infections typically 
includes systemic and/or oral anti-virals are used, such as famciclovir, acyclovir, valaciclovir, or 
penciclovir. However, there is always a concern for the development of drug resistance. 
Although the former are traditional treatments for herpes simplex labialis, laser phototherapy 
may be a new turning point in the treatment of cold sores.  This thesis uses two randomized control trials 
and a case report to compare the effectiveness of laser phototherapy to other traditional methods of 
treatment for herpes simplex labialis.   
 
Objective 
The objective of this EBM review is to determine if laser phototherapy an effective treatment for 
herpes simplex labialis. 
 
Methods 
The studies used in this thesis are two randomized controlled trials (RTCs) and one case study.  
Search strategy methods were based on the population of interest, interventions, comparisons between 
the control and experimental groups, and the outcomes of the studies.  The population of interest was 
patients with herpes simplex labialis greater than or equal to 18 years old.  The interventions included 
phototherapy treatment using various wavelengths of light.  The experimental group received laser 
phototherapy for treatment, whereas the control group received an alternative, such as a traditional 
medical treatment (anti-viral) or no treatment.  The outcomes measured were decreasing the healing 
time and/or size of herpes simplex labialis lesions. 
The study conducted by Marotti et al was a case report that followed 4 patients referred from the 
School of Dentistry of the University of Sao Paulo between the ages 21-52 with herpes simples labialis.1  
Inclusion criteria required patients to be in the vesicular stage when treatment began, and exclusion  
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criteria determined that participants could not be past the vesicular stage of an outbreak.1  Treatment for 
each patient included rupture of the vesicles, application of 0.01% methylblue solution to the lesion(s) 
for 5 minutes, followed by a phototherapy session using a 660 nm laser for over 2 minutes at 4 points for 
a total of 4 treatments.1 The 4 laser treatments occurred at initial presentation, after 24 hours, 72 hours, 
and 1 week later.1 There was no control group for this study. 1  To evaluate the efficacy of the study as 
well as patient healing progress, visible improvement was documented with photographs of the patients’ 
lips.1  Photographs were taken before intervention, after the application of methyl blue solution, 
immediately after phototherapy treatments and/or 24 hours post laser treatment, and 1 week post laser 
treatment.1  One of the participants had a photograph showing improvement 6 hours status post laser 
phototherapy.1   
The study conducted by de Carvalho et al was a RTC from March 2003 to July 2004 that 
included 71 patients referred from the School of Dentistry of the University of Sao Paulo with an 
average age of 28.8 years.  Inclusion criteria required patients to have recurrent outbreaks, with at least 3 
in the past year, and exclusion criteria required that participants were not experiencing a first-time 
outbreak, had a previous laser phototherapy treatment, or previously used systemic acyclovir as 
treatment.5  The experimental group included 41 patients and was treated with 1 session of phototherapy 
per week for 10 weeks using a GaAlAs laser at 750 nm, 60 mW, with a beam size of 0.4 cm3.5  The 
duration of laser exposure was either 2 or 3 seconds, depending on the stage of the lesion. 5  Lesions 
were treated for 3 seconds if the participant was experiencing a prodrome, or had vesicles or crusts. 5  
Lesions were treated for 2 seconds for any other stage. 5  The laser was exposed to 30 different points on 
the participants’ lips: slightly above the vermillion border, through middle of the lip, and at the transition 
to the labial mucosa. 5 Patients in the control group included 30 patients who were treated with topical  
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5% acyclovir five times per day.5  The lesions were measured based on size using a scoring scoring 
system: 0 = absent, 1 = small (0.1-2.0 mm), 2=  medium (2.1-5.0 mm), and 3 = large (>5.0 mm).5  
The study performed by Dougal et al was a RTC from January 2007-May 2008 that included 87 
patients over the age of 18 years old who were recruited from general practice surgeries and the general 
public .4 Inclusion criteria involved patients with only recurrent oro-facial herpes simplex labialis (lip  
lesions only) who had 3 or greater outbreaks within the last year.4  Exclusion criteria involved other 
locations of herpes simplex, usage of anti-retroviral treatment or systemic steroids, a major systemic 
illness, radiotherapy or chemotherapy, or diagnosis of malignancy.4  Patients contacted the study 
researchers within 24 hours of an outbreak.  A nurse or research team volunteer would see the patient 
within 36 hours of reporting an outbreak and approve initiation of treatment with the hand-held 1072 nm 
laser device or placebo. 4   The participants were treated with phototherapy using a hand-held light 
source of even intensity for 3 minutes per treatment that was prescribed for home use by the patient 
three times per day for 2 days.4  The experimental group with 41 participants was exposed to the active 
LED 1072 nm infrared light source 3 times per day for 2 days.4  The control group with 47 participants 
was exposed to an identical appearing LED light source without the infrared laser component (a 
“dummy LED”) 3 times per day for 2 days.4  The variable examined in this study was healing time, 
defined by the time that it took for the herpes simplex labialis lesions to fully resolve with the 
underlying skin to “completely re-epithelialize.”4  Participants were seen every 2-3 days, at which point 
they reported a healing time, recorded in hours.4 
The articles obtained for this EMB review were searched for in PubMed.  I chose these particular 
articles because each one was able to help to answer my clinical question, involved patient orientated 
outcomes, and could be practiced within the scope of the PA practice.  Key words used to search and  
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obtain articles included “phototherapy” and “herpes simplex labialis.”  All of the articles were published 
in English between 2009 and 2013 in peer-reviewed journals.  Inclusion criteria involved patients with 
recurrent herpes simplex labialis outbreaks who were greater than or equal to 18 years old.  Patients 
were excluded from my search who had genital herpes, a first time labial outbreak, or studies that used 
other methods in conjunction with phototherapy treatments.  Data from de Carvalho et al and Marotti et 
al studies were reported as continuous and could not be converted to dichotomous data.   The study 
conducted by Dougal et al was reported as continuous data and was converted into dichotomous data 
that reported the ABI, RBI, and NNT.  The statistical data was reported in p-values.  
Table 1: Demographics and Characteristics of Included Studies 
 
Study Type # 
Patients 
Age 
(years) 
Inclusion Criteria Exclusion Criteria W/D Interventions 
de 
Carvalho 
(2010)5 
 
Randomized 
Control Trial 
 
71 Avg. 
28.8 
 
Recurrent herpes 
simplex labialis; 
>18 yo 
1st time outbreak, 
previous laser 
phototherapy 
treatment, or 
systemic acyclovir 
treatment 
0 2 or 3 second 
phototherapy sessions 
1x/wk x 10 wks using a 
GaAlAs laser at 780nm, 
60mW, 0.4 cm3 
Dougal 
(2013)4 
Randomized 
Control Trial 
87 >18 Recurrent oro-
facial herpes 
simplex (lip 
lesions only) with 
at least 3 episodes 
in the last year; 
>18 yo 
Locations of HSV 
other than oro-facial 
area, anti-retrovital 
tx or systemic 
steroids, major 
systemic illness, 
radiotherapy or 
chemotherapy, 
diagnosis of 
malignancy 
7 3 minute phototherapy 
sessions TID x 2 days 
with a  
hand-held device 
containing a LED 1072 
nm infrared laser 
 
Marotti 
(2009)1 
Case Report 4 21-52 Patients in the 
vesicular stage of 
a herpes simplex 
labialis outbreak; 
>18 yo 
Patients past the 
vesicular stage of an 
outbreak 
0 Manual rupturing of 
vesicles, methyl blue 
solution application, 
followed by 4 sessions 
of phototherapy (initial 
presentation, 24 hrs, 72 
hrs, & 1 wk) using a 
660 nm laser. Session 
duration=2 mins. 
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Outcomes Measured  
The goal of the study by Marotti et al was to evaluate the patient healing process (healing time + 
size) based on visible improvement by documentation with photographs of the patients’ lips.1  
Photographs were taken both after the application of methyl blue solution and after phototherapy 
treatment for this assessment.1           
de Carvalho et al compared size of the herpes simplex labialis lesions status post laser 
phototherapy versus the control group using topical 5% acyclovir.5  The lesions were measured based on 
size using a scoring scoring system: 0 = absent, 1 = small (0.1-2.0 mm), 2=  medium (2.1-5.0 mm), and 
3 = large (>5.0 mm).5 
The study performed by Dougal et al compared healing time between each group.  Healing time 
was defined by the time that it took for the herpes simplex labialis lesions to fully resolve with the 
underlying skin to “completely re-epithelialize.”4  Healing time was recorded in hours.4 
 
Results 
The study by Marotti et al demonstrated that patients with herpes simplex labials who were 
treated with laser phototherapy experienced a faster healing process, with decreased healing times and 
size.  The treatment was well tolerated without adverse effects and lesions healed for all participants by 
1 week post-treatment.  None of the patients withdrew from this study.1   
 
Table 2: 1 Week Status-Post Laser Phototherapy Treatment 
 
 
Variable 
Measured 
Case 1 Case 2 Case 3 Case 4 
Decreased 
healing time and 
size after 1 week 
Completely healed Completely healed Completely healed Completely healed 
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In the study conducted by de Carvalho et al, there was a statistically significant difference in the 
monthly average size of the herpes simplex labialis lesions between the experimental and control groups 
(p-value = 0.013).5 The monthly average lesion size for the experimental group was 0.122, as compared 
to the control group lesion size which was 0.223.5 The treatment was well tolerated without adverse 
effects.5 None of the participants withdrew from the study.5  
Table 3: Comparison of Monthly Average Lesion Size 
Experimental group 
monthly average lesion 
size 
Control group monthly 
average lesion size 
p-value 
0.122 0.223 p=0.013 
 
In the study by Dougal et al, there was a significant difference (p-value = 0.01; 95% CI 10.7-
85.3) in healing time between the experimental (129 hours) and control groups (177 hours).4  The use of 
the active LED infrared light source decreased healing time by 48 hours.4  By days 6-7, 74.2% of the of 
the experimental group participants experienced healed lesions, as compared to 44.0% of the control 
group.4 The relative benefit increase was 68.6%, which shows an increase in the rates of positive 
outcomes.4 The absolute benefit increase was 30.2%, which shows that there was a beneficial effect for 
patients using laser phototherapy as treatment.4  The number needed to treat was 4, which indicates that 
4 patients need to be treated in order to prevent an adverse outcome.4  The treatment was well tolerated 
without adverse effects.4  7 patients withdrew from this study.4	
 
Table 4: Healing Time Comparison   
 
 Experimental 
Group 
Control 
Group 
p-value CER EER ABI NNT RBI 
Healing 
Time 
(hours) 
129 177 p=0.01 0.44 0.742 30.2% 4 68.6% 
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Discussion  
The effectiveness of laser phototherapy for treatment of herpes simplex labialis regarding size 
reduction and/or decreased healing time of the lesions was examined in this EBM review by evaluating 
two RTCs and one case study.  All three peer-reviewed studies demonstrate significant improvement in            
lip lesions, which suggests patient oriented outcomes and clinical significance as a potential future cold 
sore treatment.     
The usage of laser phototherapy is part of a new approach in treating herpes simplex labialis 
outbreaks.  The mechanism of action focuses on the photo-bio-modulation effect, which is believed to 
help improve immune function and consequently, the healing process (reduced size and/or time).5  The 
photo-bio-modulation effect works to enhance immune function and collagen synthesis as chromophores  
of the mitochondria absorb photons, producing ATP and NO, thereby improving and increasing the 
healing process. This leads signaling pathways to produce leukocytes, endothelial cells, fibroblasts, anti-
bodies, ECM, mast cell degranulation, and increased macrophage activity.4, 5 
Another proposed mechanism regarding the 1072 LED infrared laser shows that it may protect 
lymphocytes that act as an immune response against herpes simplex labialis outbreaks by increasing 
iNOS (nitric oxide synthase) after laser treatment.5  iNOS produces nitrous oxide (NO), which can be an 
apoptosis inhibitor, thereby preserving lymphocytes needed for a protective immune response.5  A third 
proposed mechanism of the 1072 infrared LED laser may stimulate cytokine activation and cascade to 
increase the presence of VEGF, TNF-alpha, and IL-6, which all act positively in the immune response 
against a herpes simplex labialis outbreak.5 
The study by Marotti et al demonstrates that the usage of laser phototherapy is effective in the 
treatment of herpes simplex labialis lesions by decreasing the healing time.1 By 24 hours post treatment, 
all participants had visible improvement of the lesion, and by one week post treatment, the lesions were  
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almost undetectable.1 This finding shows that laser phototherapy has faster results than traditional 
treatments for lesions, which demonstrates patient oriented outcomes.                       
The study by de Carvalho et al, demonstrated that there was a statistical significance between the 
experimental group receiving phototherapy from the GaAlAs laser versus the control group using 5% 
acyclovir (p=0.013).5  The monthly average lesions size was reduced to nearly half after using the laser  
phototherapy treatments.5  This study provides data that supports the usage of laser phototherapy over 
the use of a topical anti-viral medication to reduce lesions size over the same period of time.5  The 
decrease in size is important to patients, since experiencing smaller lesions is less embarrassing and 
more comfortable for patients overall. 
The study by Dougal et al demonstrated that healing time in hours was decreased with the usage 
of LED phototherapy as compared to a placebo, with statistical significance (p=0.01).4  The time 
improvement between the two groups was 48 hours, which demonstrates clinical significance and 
patient oriented outcomes in using phototherapy as cold sore treatment.4  A full 2 day improvement is an 
attractive quality to patients considering this form of laser phototherapy treatment.4     
Although the studies used in this EBM review provide support for the treatment of herpes 
simplex labialis, there are some discrepancies in study design.  The study conducted by Marotti et al had 
some inconsistencies regarding reporting of the photographed results.  The participants’ photographed 
results were not all taken at the same point, or extra photographs were taken for some participants over 
others.1 For example, case 1 was photographed 6 hours status post treatment, whereas the other cases did 
not.1  Also, case 2 had pictures taken before and after methyl blue treatment, whereas the other cases 
only had photographs taken after methyl blue was applied.1 To enhance the validity of the results,  
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patients should have been photographed consistently throughout the course of the study and at the exact 
same time periods. 
Additionally, the study by Dougal et al proposed a suggestion that may not be conclusive or 
valid based on the study design.  The authors state that the use of the LED laser is effective at all stages 
of the cold sore lesion breakout, where as the usage of acyclovir can only begin in the early stages of 
lesions (i.e. with prodrome or within 72 hours of the lesion appearance).4  However, this claim is 
difficult to make since the participants of the study were required to report within 24 hours of lesion 
appearance and had to be seen by a nurse within 36 hours.4  This shows that participants of the study 
could only have a lesion for a maximum of 72 hours, which is also the maximum time that allows for 
acyclovir to be effective.4  Since 72 hours was the maximum time participants could have had a cold 
sore to participate, it is difficult to claim that the laser is effective in all stages of the breakout. 
The limitations of using laser phototherapy may hinder its indication for treating herpes simplex 
labialis in the future.  Availability or access to laser phototherapy, guaranteed insurance coverage, and 
training operators of the machines are all limitations to using this form of treatment.  These could be 
large limitations just for the treatment of a self-limiting lesion that doesn’t typically require medically 
necessary treatment in most patients.  Most patients seek treatment in primary care offices for lesion 
annoyance, discomfort, or cosmetic reasons.  However, insurance may deny such a costly treatment for a 
non-emergent, self-limiting problem that can be treated with inexpensive, prescription topical or 
systemic antivirals or over the counter topicals such as Abreeva.   
A consideration for future studies in laser phototherapy treatments is testing with different 
wavelengths with the same type of laser or different lasers with the same wavelength.  Another future 
study could evaluate different stages of the cold sore to determine the most effective time to treat lesions  
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using laser phototherapy.  Any of the proposed studies could have an effect on the healing time or size 
of the lesions, which could change the healing process.  
Conclusion 
Although there are multiple systemic, topical, and homeopathic treatments available for herpes 
simplex labialis outbreaks, laser phototherapy may eventually become the new standard of care for cold 
sore treatment.  The classic usage of anti-viral medical therapy for treatments can also lead to viral  
resistance, systemic drug reactions, and non-compliance of drug application due to cosmetic appearance 
or frequency.  The studies used in this EBM review have demonstrated the effectiveness of laser 
phototherapy for treatment of herpes simplex labialis.  The improved healing time and/or size decrease 
is important to patients, as herpes simplex labialis lesions are uncomfortable and unsightly for patients.  
There are limitations to this type of treatment, and perhaps future progressions in medicine and 
insurance coverage will help to make this type of treatment attainable for the standard of care.  Laser 
phototherapy may also be used in the future as a prophylaxis for those prone to outbreaks.  Overall, it is 
a promising intervention for cold sore treatment and should continue to be studied for the future.   
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